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Abstract: Ruscus aculeatus L. is a subshrub used in traditional medicine in different parts of the world,
namely in Europe and the Iberian Peninsula. According to reported folk knowledge, the aerial parts
are mainly used as diuretics and the underground organs are used for the treatment of disorders
of the urinary system and as a laxative. In this work, the aerial part and the roots and rhizomes of
R. aculeatus were chemically characterized with regard to the content of phenolic compounds and
bioactive properties. Aqueous (infusions and decoctions) preparations and hydroethanolic extracts
from the two mentioned parts of the plant were prepared. Nine phenolic compounds were detected
in all the extracts. Apigenin-C-hexoside-C-pentoside isomer II was the major compound in aqueous
extracts and, in the hydroethanolic extract was quercetin-O-deoxyhexoside-hexoside followed by
apigenin-C-hexoside-C-pentoside isomer II. All extracts revealed antioxidant activity and potential
to inhibit some of the assayed bacteria; aqueous extracts of the aerial part and infusions of roots and
rhizomes did not show cytotoxic effects on a non-tumor primary cell culture. This preliminary study
provides suggestions of the biological potential associated with the empirical uses and knowledge of
this species, in particular its bioactivities.
Keywords: Ruscus aculeatus L.; aerial part; roots and rhizomes; phenolic compounds; bioactivities
1. Introduction
In addition to providing oxygen, plants are a source of natural compounds that are
also used by humans since they have aromatic, medicinal, and food capabilities [1]. The
use of plants for medicinal purposes is based on ancient knowledge, passed down from
generation to generation, and for centuries they have been the only resource in terms of
medical, curative, or preventive care for many populations [2]. Medicinal plants have been
and are still used in the development of new drugs for the treatment of several diseases.
Their popular use is mostly based on empirical knowledge and beliefs; therefore, some of
their therapeutic applications lack scientific foundation [3].
However, such species are called medicinal plants because they have therapeutic
benefits, which must be linked to particular substances, namely active ingredients that
might have a recognized pharmacological action. Thus, it is important to know which parts
of the plants are traditionally used for medicinal purposes, how are they processed and
applied, and which chemical compounds are responsible for their therapeutic properties.
The increased interest in new herbal medicines has led to the discovery of new compounds
of therapeutic interest, such as steroids, alkaloids, saponins, terpenoids, and glycosides [4].
The nature of a plant-based medicine is determined by the content of different active
components, and the potential that each plant has in these components can contribute to
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an excellent therapeutic complement to conventional medicine [2]. Thus, according to the
World Health Organization (WHO), wild or cultivated species are used as medicinal, both
in traditional/folk medicine and in complementary medicine [5].
Ruscus aculeatus L. is a Eurasian species of the Monocotyledon group, currently part
of the Asparagaceae botanical family reported as a medicinal species in European folk
medicine [6–9]. The plant is a small subshrub, always green, with thick underground rhi-
zomes [10]. The empirical medicinal uses are related with aerial parts are used empirically
as diuretics and, the underground parts (roots and rhizomes) to alleviate the symptoms of
several disorders of venous insufficiency, edema, urinary system, premenstrual syndrome,
and hemorrhoids [8,11].
Few research groups have already studied this species [11–13]; the same authors report
that the main active ingredients found in R. aculeatus are steroidal saponins (rucogenin and
neoruscogenin), which are responsible for its pharmacological effects; other constituents
have been isolated, including sterols, triterpenes, flavonoids, coumarins, sparteine, tyra-
mine, and glycolic acid. Moreover, some of the traditional applications of the species seem
related to particular compounds, since the highest concentration of ruscogenins is located
in the rhizome [11].
This work represents the detailed characterization of R. aculeatus regarding the phe-
nolic compounds of the aerial (laminar stems and lateral branches) and the underground
(rhizomes with roots) parts. In addition, the bioactive potential of the hydroethanolic
and aqueous extracts was also assessed in terms of their antioxidant, anti-tumor, anti-
inflammatory, hepatotoxicity, and antimicrobial properties. Therefore, this work intends to
contribute to the knowledge of the chemical composition of this species and to relate it to
its documented empirical uses.
2. Results and Discussion
The identification of individual phenolic compounds was carried out considering their
retention times, whenever possible in comparison with commercially available standards,
and both UV and MS spectra. Data obtained by HPLC-DADESI/MS analysis (retention
time, λmax, pseudomolecular ion ([M − H]−), and main fragment ions in MS2), phenolic
compounds’ tentative identifications, and respective quantification are present in Table 1.
The study revealed the presence of nine phenolic compounds, one caffeic acid deriva-
tive, and eight flavonoids, namely six C-glycosylated derivatives of apigenin and two
O-glycosylated derivatives of quercetin and kaempferol.
Peak 1 showed a pseudomolecular ion [M−H]− at m/z 341 and MS2 fragments at m/z
179 and 135 consistent with the loss of a caffeic acid, therefore, being tentatively identified
as caffeic acid hexoside. Peaks 2/5/7 ([M − H]− at m/z 563) were all tentatively identified
as apigenin-C-hexoside-C-pentoside isomers I, II, and III, respectively. On the other hand,
peaks 3/4/6, also showing a pseudomolecular ion at [M − H]− at m/z 563 were tentatively
identified as apigenin-C-pentoside-C-hexoside isomers I, II, and III, respectively. The
differentiation between isomers and sugar position took into account what was previously
described by some authors Tahir et al. [14] and Ferreres et al. [15]. Finally, peaks 8 ([M −
H]− at m/z 609) and 9 ([M − H]− at m/z 593) presented a single MS2 fragment at m/z 301
and 285, aglycones of quercetin and kaempferol, respectively, corresponding to the loss of
a 308 u (146 u + 162 u, deoxyhexoside + hexoside moieties, respectively), and therefore,
being tentatively identified as quercetin-O-deoxyhexoside-hexoside and kaempferol-O-
deoxyhexoside-hexoside, respectively.
The hydroethanolic extracts of the aerial part presented the highest levels of phenolic
compounds (107 ± 3 mg/g extract, Figure 1), followed by the aqueous extracts, the
decoction (18 ± 1 mg/g extract), and the infusion (14.6 ± 0.3 mg/g extract). All extracts
performed with aerial parts showed the same phenolic profile; however, the same was not
verified for the roots, where no phenolic compounds were identified.
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Table 1. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, tentative identification and quantification of the phenolic compounds








MS2 (m/z) Tentative Identification
Quantification
Hydroethanolic Infusion Decoction
1 5.96 320 341 179 (100), 135 (20) Caffeic acid hexoside 1.42 ± 0.03 a 0.013 ± 0.001 c 0.091 ± 0.005 b
2 10.49 334 563 545 (21), 473 (100), 443 (91), 413(*), 383 (36), 353 (41), 297 (*) Apigenin-C-hexoside-C-pentoside isomer I 2.8 ± 0.1 a 0.446 ± 0.007 c 0.87 ± 0.01 b
3 12.05 334 563 545 (34), 473 (100), 443 (63), 413(*), 383 (29), 353 (24), 297 (*) Apigenin-C-pentoside-C-hexoside isomer I 1.36 ± 0.01 a 0.162 ± 0.005 c 0.45 ± 0.02 b
4 12.82 335 563 545 (29), 473 (100), 443 (79), 413(*), 383 (32), 353 (29), 297 (*) Apigenin-C-pentoside-C-hexoside isomer II 13.1 ± 0.3 a 3.19 ± 0.08 b 2.96 ± 0.01 c
5 13.15 335 563 545 (17), 473 (69), 443 (100), 413(*), 383 (19), 353 (23), 297 (*) Apigenin-C-hexoside-C-pentoside isomer II 32 ± 1 a 5.63 ± 0.04 c 7.4 ± 0.3 b
6 14.54 338 563 545 (18), 473 (100), 443 (81), 413(5), 383 (26), 353 (34), 297 (*) Apigenin-C-pentoside-C-hexoside isomer III 3.7 ± 0.1 a 0.528 ± 0.001 b 0.52 ± 0.01 b
7 14.72 340 563 545 (15), 473 (71), 443 (100), 413(*), 383 (15), 353 (23), 297 (*) Apigenin-C-hexoside-C-pentoside isomer III 7.1 ± 0.4 a 0.79 ± 0.02 c 1.68 ± 0.02 b
8 16.88 353 609 301 (100) Quercetin-O-deoxyhexoside-hexoside 39 ± 2 a 3.6 ± 0.2 b 4.0 ± 0.2 b
9 20.05 340 593 285 (100) Kaempherol-O-deoxyhexoside-hexoside 6.23 ± 0.05 a 0.175 ± 0.009 c 0.42 ± 0.02 b
Total Phenolic Compounds 107 ± 3 a 14.6 ± 0.3 c 18 ± 1 b
* relative percentage less than 5%; calibration curves used in the quantification: standard calibration curves: caffeic acid (y = 388345x + 406369, R2 = 0.99; detection limit (LOD) = 0.78 µg/mL; quantification limit
(LOQ) = 1.97 µg/mL, peak 1), apigenin-6-C-glucoside (y = 107025x + 61531, R2 = 0.998; LOD = 0.19 µg/mL; LOQ = 0.63 µg/mL peaks 2, 3, 4, 5, 6, 7); quercetin-3-O-rutinoside (y = 13343x + 76751, R2 = 0.999;
LOD = 0.21 µg/mL; LOQ = 0.71 µg/mL, peaks 8 and 9). Different letters in the same line mean significant differences (p < 0.05).
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Figure 1. Phenolic profile of hydroethanolic extract of the aerial part, recorded at 280 nm (A) and
370 nm (B). Peak numbering is indicated as defined in Table 1.
Luís et al. [16] report the existence of two phenolic compounds, p-coumaric acid and
quercetin in the methanolic extracts of the aerial part of R. aculeatus; this study reports the
existence of other phenolic acids, namely, gallic acid, vanillic acid, caffeic acid, chlorogenic
acid, syringic acid, ferulic acid, and ellagic acid, in the aerial parts of R. aculeatus. Another
study, Gonçalves et al. [17] evaluated total phenolic content, measured through the Folin
Ciocalteu colorimetric method, and reports 121.73 µmol GAE g/dw, but according to the
applied methodology, it is not possible to make comparisons with our study.
The antioxidant activity of the hydromethanolic and aqueous extracts prepared from
the aerial and the underground parts of R. aculeatus were tested by two different in vitro
assays, which ensured an overview of the antioxidant activity in differing surroundings.
The results of the TBARS formation inhibition and OxHLIA assays are presented in Table 2.
As it can be seen, significant differences between the evaluated extracts were observed.
The hydroethanolic extract showed the best activity in the TBARS assay, for the aerial part
and for the roots and rhizome, with an EC50 of 0.28 and 0.78 mg/mL, respectively. In turn,
the decoction extract, both from the aerial part and roots and rhizome, showed the lowest
activity, with EC50 values of 0.88 and 1.55 mg/mL, respectively.
It has been described that the extractions carried out with a higher percentage of water
have the capacity to extract more polar compounds, whereas methanol or ethanol:water
mixtures present higher extraction yields [18].
The antihemolytic properties of the extracts were assessed in an ex vivo erythrocyte
system by the OxHLIA assay. The infusion of the aerial part and the hydroethanolic extract
of the roots and rhizome presented an IC50 value of 236 and 230 µg/mL, respectively,
values required to protect half of the erythrocyte population from the hemolytic action
caused by the oxidative agent for 60 min. At the same time, the decoction of the aerial
part and roots and rhizome presented IC50 values of 427 and 661 µg/mL, respectively.
The aqueous extract of the aerial part only revealed the capacity to prevent the hemolysis
for 60 min, while the hydroethanolic extract did not reveal antihemolytic activity. Plant
extracts are complex mixtures of different antioxidant and non-antioxidant compounds that
can act at several levels of cell oxidative degradation and this assay, by using erythrocytes,
offers test conditions that are very close to the in vivo situation [19].
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Table 2. Antioxidant, cytotoxicity, hepatotoxic and anti-inflammatory activity of the hydroethanolic extracts, infusion and decoction preparations of R. aculeatus (mean ± SD, n = 9).
Aerial Part Roots and Rhizomes Positive Control
Hydroethanolic Infusion Decoction Hydroethanolic Infusion Decoction Trolox (µg/mL)
Antioxidant activity
TBARS (EC50, mg/mL) a 0.28 ± 0.01 f 0.49 ± 0.03 e 0.88 ± 0.01 c 0.78 ± 0.04 d 1.00 ± 0.01 b 1.55 ± 0.03 a 5.8 ± 0.6
OxHLIA (IC50, µg/mL) b
∆t = 60 min n.a. 236 ± 16 c 427 ± 36 b 230 ± 11 c 646 ± 33 a 661 ± 25 a 21.8 ± 0.2
∆t = 120 min n.a. n.a. n.a. 383 ± 13 c 1389 ± 48 a 1198 ± 28 b 43.5 ± 0.3
Cytotoxicity (GI50, µg/mL) c Ellipticine
HeLa 31 ± 4 d 373 ± 27 a 270 ± 20 b 98 ± 6 c 302 ± 25 b 111 ± 6 c 0.9 ± 0.1
NCI H460 70 ± 4 d 273 ± 15 b 302 ± 7 a 51 ± 3 e 201 ± 17 c 69 ± 2 d.e 1.03 ± 0.09
MCF7 70 ± 3 c >400 >400 89 ± 4 b 350 ± 16 a 94 ± 2 b 1.21 ± 0.02
HepG2 72 ± 3 d >400 260 ± 22 b 71 ± 2 d 300 ± 12 a 168 ± 9 c 1.10 ± 0.09
Hepatotoxicity (GI50, µg/mL) c
PLP2 152 ± 8 c >400 >400 179 ± 7 b >400 265 ± 9 a 2.3 ± 0.2
Anti-inflammatory activity (EC50 µg/mL) d Dexamethasone
Production of nitric oxide (NO) in RAW264.7 60 ± 5 c >400 >400 111 ± 4 b >400 129 ± 5 a 16 ± 1
n.a.: no activity. a EC50 values: extract concentration corresponding to 50% of antioxidant activity. b IC50 values: extract concentration necessary to keep 50% of the erythrocyte population intact for 60 and 120 min.
c GI50 values correspond to the sample concentration responsible for 50% inhibition of growth in tumor cells or in a primary culture of liver cells-PLP2. d EC50 values correspond to the extract concentration
achieving 50% of the inhibition of NO-production. Different letters in the same line mean significant differences (p < 0.05).
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To date, there are few studies evaluating the antioxidant activity of the aerial part
and, to the best of the authors’ knowledge, the present study provides a first report of the
antioxidant activity of roots and rhizomes. Luís et al. [16] described that the methanolic
extract of the aerial part showed little antioxidant activity in the DPPH assay, with an IC50
value of 171.9 mg/L. Other studies, using also the aerial part, reported that ethyl acetate
and butanol extracts were the ones that revealed the best activity for the DPPH assay, and
obtained EC50 values of 158 and 173 µg/mL, respectively [20] and, Jakovljević et al. [12]
obtained EC50 values of 183 µg/mL of ethyl acetate extracts.
The lower activity verified in this chemical assay may be related to the variation
of compounds due to different states of the growing cycle, the gathering season, diverse
climate, and landscape conditions, as well as the use of different solvents for the preparation
of the extracts, since the solvent has an influence on the extraction methodology [21].
Kobus-Cisowska et al. [22], in a study using Asparagus officinalis L., which belongs to
the same family as R. aculeatus, also reported the antioxidant potential of green, purple,
and white varieties, with the first one revealing the greater antioxidant capacity, in the
DPPH assay. According to Jakovljević et al. [12], the antioxidant activity of plants is mainly
associated with their bioactive compounds, especially phenolics, flavonols, and flavonoids
and their higher content.
Compared to chemical methods (such as DPPH and reducing power, among others),
the herein employed TBARS and OxHLIA methods use biological tissues (porcine brain
and sheep erythrocytes), therefore, being methods that reproduce and resemble in vivo
conditions which makes them more predictive assays.
The results obtained for the four human tumor cell lines and the primary culture of
non-tumor cells are present in Table 2, and are expressed in values of the concentration of
extract responsible for 50% inhibition of cell growth—GI50, in µg/mL.
It is observed that, with the exception of the infusion of the aerial part (for the lines
MCF7 and HepG2) and decoction extracts (line MCF7), all the remaining extracts presented
effective results in the inhibition of the tested cell lines; the hydroethanolic extract of the
aerial part revealed a lower GI50, which may be related to the high levels of phenolic
compounds found in this extract.
The infusion and decoction of the aerial part, and the infusion of the roots and
rhizomes did not show cytotoxic effects on a non-tumor primary cell culture. In turn, the
hydroethanolic extracts of the aerial part and roots and rhizomes, as well as the decoction
of roots and rhizomes, presented toxicity towards the liver primary cell culture (PLP2).
These results are in agreement with those described by Bassil et al. [23], in which they
explored the effect of ethanolic extract on leukemia acute lymphocyte cancer proliferation,
and concluded that the R. aculeatus extract is not a good candidate for the development of
anti-tumor drugs, as it demonstrated a cytotoxic effect, although further studies are needed
to confirm this statement.
Chen et al. [24] evaluated the cytotoxic activity of Ornithogalum saundersiae (Aspara-
gaceae) and found that the compound Osaundersioside C inhibited specific cytotoxicity
in relation to the MCF-7 cell line with IC50 values of 0.20 µM, similar to the positive
control paclitaxel.
Few studies evaluate the cytotoxic and hepatotoxic effects in different extracts of R.
aculeatus, making it difficult to compare the results with the literature. Additional studies
would be essential, possibly involving the fractionation and identification of the active
compounds, in order to better understand the action and potential of these types of extracts
and compounds.
Regarding the anti-inflammatory properties, for the range of tested concentrations (up
to 400 µg/mL), in the extracts of infusion and decoction of the aerial part, as well as the infu-
sion of the roots and rhizome, the results indicated the absence of activity in LPS-activated
murine macrophages since no decrease of nitric oxide levels was observed (Table 2).
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The hydroethanolic extract of the aerial part was the one that presented an effective
result, 60 µg/mL being necessary to promote the 50% inhibition of nitric oxide production,
which may also be related to the high presence of phenolic compounds in this extract.
Comparing the aqueous extracts of the aerial part with those of the roots and rhizome, only
the decoction of the roots and rhizome present anti-inflammatory activity (129 µg/mL).
These results are in agreement with those described by different authors, who demonstrate
that plants of the Asparagaceae family have anti-inflammatory properties mainly due to
the existence of steroidal saponins, primarily ruscogenin [25,26].
Table 3 shows the results of the antimicrobial activity of the hydroethanolic and
aqueous extracts of R. aculeatus against three Gram-positive and five Gram-negative multi-
resistant pathogenic strains, isolated from hospitalized patients. In general, all extracts
present potential effects against the bacterial strains tested in this study; Gram-positive
bacteria present lower MIC values and, therefore, superior sensitivity when compared with
Gram-negative bacteria. The infusion and hydroethanolic extracts of the aerial part, were
effective against Gram-positive bacteria with an MIC of 10 mg/mL.
Regarding the inhibition of Gram-negative bacteria, only the infusion and hydroethano-
lic extracts of the aerial part presented an MIC of 10 mg/mL. The decoction of the aerial
part was effective against the MRSA strain—methicillin-resistant S. aureus, with an MIC
of 5 mg/mL. Infusion of the root and rhizome present the smallest antibacterial potential,
with MIC and MBC values higher than 20 mg/mL for the tested bacteria.
According to the authors of [20], the ethyl acetate extract of R. aculeatus demonstrated
bacteriostatic activity against S. aureus and bactericidal activity against E. coli and P. aerugi-
nosa. One study demonstrated that the infusion and ethanolic extracts of the roots were less
effective against the fungus C. albicans (ATCC 1023) [27]. A study in which the antimicrobial
activity of the methanolic extract of leaves of Agave sisalana (Asparagaceae) was measured
found that they did not reveal antimicrobial activity against the microorganisms used (S.
aureus and K. pneumoniae) [28].
In general, the extracts evaluated in this work were effective against Gram-positive
bacteria, which can be explained by the fact that this group of microorganisms has a less
complex cell wall compared to Gram-negative bacteria. It should be noted that in this
work, the microorganisms were obtained from clinical isolates, which often have greater
resistance to antibiotics compared to commercial strains.
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Table 3. Antibacterial activity (MIC and MBC, mg/mL) of the hydroethanolic extracts, infusion and decoction preparations of R. aculeatus.
Aerial Part Roots and Rhizome Negative Controls





MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Gram-negative bacteria
Escherichia coli 10 >20 >20 >20 20 >20 20 >20 >20 >20 20 >20 <0.15 <0.15 <0.0078 <0.0078 n.t. n.t.
Klebsiella pneumoniae 20 >20 20 >20 20 >20 >20 >20 >20 >20 >20 >20 10 20 <0.0078 <0.0078 n.t. n.t.
Morganella morganii 10 >20 10 >20 20 >20 >20 >20 >20 >20 >20 >20 20 >20 <0.0078 <0.0078 n.t. n.t.
Proteus mirabilis 20 >20 >20 >20 >20 >20 >20 >20 >20 >20 >20 >20 <015 <0.15 <0.0078 <0.0078 n.t. n.t.
Pseudomonas aeruginosa >20 >20 >20 >20 >20 >20 >20 >20 >20 >20 >20 >20 >20 >20 0.5 1 n.t. n.t.
Gram-positive bacteria
Enterococcus faecalis 10 >20 10 >20 20 >20 20 >20 20 >20 >20 >20 <0.15 <0.15 n.t. n.t. <0.0078 <0.0078
Listeria monocytogenes 10 >20 10 >20 10 >20 >20 >20 >20 >20 >20 >20 <0.15 <0.15 <0.0078 <0.0078 n.t. n.t.
MRSA 10 >20 10 >20 5 >20 >20 >20 20 >20 10 >20 <0.15 <0.15 n.t. n.t. 0.25 0.5
MRSA—Methicillin-resistant Staphylococcus aureus; MIC—minimal inhibitory concentration; MBC—minimal bactericidal concentration; n.t.—not tested.
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3. Materials and Methods
3.1. Plant Material
Samples of R. aculeatus were harvested in April 2019 inside woodlands and hedgerows,
in Valpaços, Vila Real, Portugal. Two distinct parts of the plant were gathered, namely the
aerial part (cladodes or laminar stems and lateral branches) and the underground organs
(rhizomes with roots). These plant materials were cleaned of soil remains, lyophilized
(FreeZone 4.5, Labconco, Kansas City, MO, USA), and reduced to a fine powder that was
stored in sealed plastic bags.
Considering the abundance of this species at the growing site and its strategy of
reproduction and natural regeneration (the seeds are relatively abundant and distributed by
birds, and the plant also propagates through its vegetative parts, rhizomes), the harvesting
of this wild material was done in a sustainable way and did not put wild populations at risk.
3.2. Hydroethanolic Extracts and Aqueous Preparations
The plant material was used to prepare hydroethanolic extracts, infusions, and decoc-
tions preparations. The preparation/extraction methods were selected according to the
traditional/empirical uses of the different parts of the plant [13,20]. Hydroethanolic ex-
tractions were performed by stirring the plant material (~3 g) with 45 mL of ethanol/water
solution (80:20, v/v) under constant magnetic stirring, at room temperature, for 1 h. The
preparation was filtered through a Whatman filter paper No. 4 and the residue was
re-extracted and the combined filtrates were then evaporated under pressure at 40 ◦C
(rotary evaporator Buchi R-2010, Flawil, Switzerland) and subsequently lyophilized.
Approximately 3 g of plant material was infused with 100 mL of freshly boiled distilled
water (heating plate, VELP scientific), left aside for 5 min, and subsequently filtered through
Whatman filter paper No 4. The resulting extracts were frozen and lyophilized.
The plant material was decocted by adding 100 mL of distilled water (~3 g), and
boiled for 5 min. Subsequently, the mixtures were left to stand for 5 min and then filtered
through Whatman No. 4 paper. The obtained decoctions were frozen and lyophilized.
3.3. Analysis of Phenolic Compounds
Phenolic compounds were analyzed in the hydroethanolic extracts and aqueous
preparations, which were re-dissolved in ethanol/water (80:20, v/v) and water, respectively,
to a final concentration of 10 mg/mL and filtered thought 0.22-µm disposable filter disks.
The analysis was performed in an HPLC system (Dionex Ultimate 3000 UPLC, Thermo
Scientific, San Jose, CA, USA) coupled with a diode-array detector (DAD, using 280 and
370 nm as preferred wavelengths) and a Linear Ion Trap (LTQ XL) mass spectrometer
(MS, Thermo Finnigan, San Jose, CA, USA) equipped with an electrospray ionization
(ESI) source. Separation was made in a Waters Spherisorb S3 ODS-2 C18 column (3 µm,
4.6 × 150 mm; Waters, Milford, MA, USA). The equipment and operating conditions were
previously described by the authors [29] as well as the identification and quantification
procedures. The phenolic standards (caffeic acid, apigenin-6-C-glucoside, and quercetin-3-
O-rutinoside) were acquired from Extrasynthèse, Genay, France. The results were expressed
as mg per g of extract.
3.4. Evaluation of Bioactive Properties of Extracts
The evaluation of the bioactive potential of lyophilized hydroethanolic extracts and
aqueous preparations was performed in vitro.
3.4.1. Thiobarbituric Acid Reactive Substances (TBARS) Formation Inhibition Capacity
The extracts prepared above were re-dissolved in water and subjected to dilutions from
5 to 0.0390 mg/mL. Porcine (Sus scrofa) brains were obtained from animals slaughtered at
officially licensed premises, dissected, and homogenized with Tris-HCl buffer (20 mmol/L,
pH 7.4) to produce a brain tissue homogenate, which was centrifuged at 3000× g for 10 min.
An aliquot (100 µL) of the supernatant was incubated with the different concentrations of
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the extract solutions (200 µL) in the presence of FeSO4 (10 mmol/L; 100 µL) and ascorbic
acid (0.1 mmol/L; 100 µL) at 37 ◦C for 1 h.
The reaction was stopped by the addition of trichloroacetic acid (28 g/100 µL, 500 µL),
followed by thiobarbituric acid (TBA, 2 g/100 mL, 380 µL), and the mixture was then heated
at 80 ◦C for 20 min. After centrifugation at 3000× g for 10 min to remove the precipitated
protein, the color intensity of the malondialdehyde (MDA)-TBA complex in the supernatant
was measured at 532 nm; the inhibition ratio (%) was calculated using the following formula:
[(A− B)/A]× 100%, where A and B correspond to the absorbance of the control and extract
sample, respectively [30]. The results were expressed in EC50 values (mg/mL, sample
concentration providing 50% of antioxidant activity). Trolox (Sigma-Aldrich, St. Louis, MO,
USA) was used as the positive control.
3.4.2. Oxidative Hemolysis Inhibition (OxHLIA) Capacity
The antihemolytic activity of the extracts was evaluated by the oxidative hemolysis
inhibition assay (OxHLIA), using erythrocytes isolated from healthy sheep blood and
centrifuged at 1000× g for 5 min at 10 ◦C. After discarding the plasma and buffy coats, the
erythrocytes were first washed with NaCl (150 mM) and then three times with phosphate-
buffered saline (PBS, pH 7.4). The erythrocyte pellet was then resuspended in PBS to
obtain a concentration of 2.8% (v/v). Using a flat-bottom 48-well microplate, 200 µL of
the erythrocyte solution were mixed with 400 µL of PBS solution (control), antioxidant
extracts dissolved in PBS, or water (for complete hemolysis). After pre-incubation at 37 ◦C
for 10 min with shaking, 2,2′-azobis(2-methylpropionamidine) dihydrochloride (AAPH,
160 mM in PBS, 200 µL) was added to each well and the optical density was measured
at 690 nm. The results were expressed as the delayed time of hemolysis (∆t), which was
calculated according to the equation: ∆t (min) = Ht50 (sample) −Ht50 (control), where Ht50
is the time (min) corresponding to 50% hemolysis, graphically obtained from the hemolysis
curve of each antioxidant sample concentration. The ∆t values were then correlated with
the extract concentrations, and from the correlation obtained, the extract concentration able
to promote a ∆t hemolysis delay was calculated. Trolox was used as a positive control. The
results were given as IC50 values (µg/mL) at ∆t 60 and 120 min, i.e., extract concentration
required to protect 50% of the erythrocyte population from the hemolytic action for 60 and
120 min [19].
3.4.3. Cytotoxicity Activity
The cytotoxicity capacity of the extracts was evaluated using four human tumor cell
lines: MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), HeLa (cer-
vical carcinoma), and HepG2 (hepatocellular carcinoma) from DSMZ (Leibniz-Institut
DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH). The sulforho-
damine B (SRB, Sigma-Aldrich, St Louis, MO, USA) assay was performed according to a
procedure previously described in detail by the authors [31].
The cell growth inhibition was calculated according to the equation: ((Abssample extract
and cells− 0.05)/(Abscontrol − 0.05)× 100). Ellipticine (Sigma-Aldrich, St. Louis, MO, USA)
was used as the positive control, and the results were expressed in GI50 values (µg/mL),
corresponding to the extract concentration that provides 50% of cell growth inhibition.
3.4.4. Hepatotoxic Activity
Hepatotoxicity of the extracts was evaluated using a primary cell culture prepared
from porcine liver (PLP2), which was prepared according to the procedure optimized
and described by the authors [32]. The tested concentration of both hydroethanolic and
aqueous extracts ranged from 400 to 6.5 µg/mL. The results were measured using the SRB
method and were expressed as GI50 values (concentration that inhibits 50% of cell growth,
µg/mL). Ellipticine was used as the positive control.
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3.4.5. Anti-Inflammatory Activity
The anti-inflammatory activity of the extracts was determined based on the nitric
oxide (NO) production by a murine macrophage (RAW 264.7) cell line, induced by the
addition of lipopolysaccharide (LPS). The tested concentration of both hydroethanolic and
aqueous extracts ranged from 400 to 6.5 µg/mL. NO production was quantified based on
nitrite concentration using the Griess Reagent System kit containing sulfanilamide, N-1-
naphthylethylenediamine dihydrochloride, and nitrite solutions following a procedure
previously described by the authors [33]. Dexamethasone was used as a positive control
while no LPS was added in negative controls.
The effect of the tested extracts in NO basal levels was also assessed by performing
the assay in the absence of LPS. The results were expressed as IC50 values (µg/mL),
corresponding to the extract concentration providing 50% inhibition of NO production.
3.4.6. Antimicrobial Activity
The antimicrobial activity of the extracts was determined against clinical isolates
obtained from patients hospitalized in the Local Health Unit of Bragança and Hospital
Center of Trás-os-Montes and Alto-Douro Vila Real, following the microdilution method
coupled to the rapid p-iodonitrotetrazolium chloride (INT) colorimetric assay described
by the authors [34]. The tested concentration of both hydroethanolic and aqueous extracts
ranged from 20 to 0.156 mg/mL.
The tested microorganisms included Gram-positive (Enterococcus faecalis, Listeria
monocytogenes, and methicillin-resistant Staphylococcus aureus) and Gram-negative
bacteria (Escherichia coli, Klebsiella pneumoniae, Morganela morganii, Proteus mirabilis,
and Pseudomonas aeruginosa). The minimum inhibitory concentration (MIC) and the
minimum bactericidal concentration (MBC) were evaluated, and different antibiotics
were used as negative control (ampicillin and imipenem for Gram-negative bacteria, and
vancomycin and ampicillin for Gram-positive bacteria). Culture broth (Muller Hinton
Broth added with 5% dimethylsulfoxide) inoculated with each bacterium was used as the
positive control [34].
3.5. Statistical Analysis
All experiments were carried out in triplicate and the results were expressed as
mean ± standard deviation (SD). The statistical analysis was performed using SPSS v. 23.0
software for Windows (IBM Corp., Armonk, NY, USA) and using the one-way analysis of
variance (ANOVA), while the comparison of means was carried out with the Tukey’s HSD
test (p < 0.05) when significant statistical differences were detected.
4. Conclusions
This work aimed to explore the biochemical characterization of a wild plant for which
few studies have been performed. Wild plants can be considered sources of bioactivities,
since they have several compounds and, consequently, different potential therapeutic
action. The present work allowed to determine the phenolic compounds in the three
extracts obtained from the aerial part and from the rhizomes and roots of R. aculeatus using
different extraction and solvent techniques, but also to evaluate their bioactive properties.
In general, this study provided innovative results in relation to the chemical character-
ization and bioactive properties of this little-studied and explored wild plant. However,
these innovative results are not enough to relate the empirical uses with the chemical
characteristics and bioactive properties demonstrated by the extracts obtained from both
the aerial and the underground parts. Therefore, it will be essential to continue exploring
the compounds and the mentioned activities, so that it is possible to corroborate and
substantiate the use of this species in traditional medicine.
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